Chronic Kidney Disease Trial, Recruiting NCT04185844 Sponsor: University of New Mexico Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT04185844
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose kidneys are filtering at a moderately reduced level (a kidney function score between 61 and 79) AND who also have a small but above-normal amount of protein in their urine, OR people whose kidneys are filtering at a more significantly reduced level (a kidney function score of 60 or below), regardless of protein in the urine (confirm with trial site for exact measurements)

Who may not be able to join:

  • People who are unable or unwilling to give their formal agreement to take part in the study
  • People whose life expectancy is less than 3 years
  • People who are currently living in a care institution or similar facility
  • People who have end-stage kidney disease (kidney failure) or who have had a kidney transplant
  • People who have kidney cancer
  • People who have myeloma (a type of blood cancer)
  • People who are currently taking medications that suppress or reduce the immune system
  • People who have polycystic kidney disease (a condition where cysts grow on the kidneys)
  • People who are currently participating in another clinical trial
  • People who are currently pregnant
  • People who are currently incarcerated
  • People who the trial investigators or coordinators assess as unlikely or unable to complete the required study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mark L Unruh, MD, University of New Mexico

Phone: 505-272-8300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of New Mexico
Registry
ClinicalTrials.gov
Start date
31 August 2020
Est. completion
30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Slope of the GFR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov